Articles: 28.11 November 2017

Apps in primary care – dawn of the docbot?

Want a GP appointment in the next hour? Don’t have time to leave your desk? Don’t feel like paying for a private service? There’s an app for that. This editorial examines the new consultation service ‘GP at hand’, where users download an app to their smartphones into which they enter their symptoms, receive advice, are issued prescriptions, and book phone or video appointments with a

More details...

37th Primary Care Update

The 37th Primary Care Update was held at the Royal Society of Medicine in September, informing healthcare professionals on the current UK management of hayfever and inflammatory bowel disease, and the challenge of an ageing population in drug and alcohol detox services. Felix David reports on some of the conference highlights

More details...

Treatment options for primary and secondary dysmenorrhoea

Dysmenorrhoea affects up to half of young women and can adversely affect quality of life, especially if severe. This article describes the distinguishing features of primary and secondary dysmenorrhoea and discusses the main treatment options for women presenting in primary care

More details...

Update of the FSRH guideline on emergency contraception

In March, the Faculty of Sexual & Reproductive Healthcare (FSRH) of the Royal College of Obstetricians and Gynaecologists updated their guideline on emergency contraception. This article provides an overview of the new guideline and its key recommendations

More details...

DPP-4/SGLT2 inhibitor combined therapy for type 2 diabetes

DPP-4 inhibitors and SGLT2 inhibitors lower blood glucose by complementary mechanisms of action, and two fixed-dose combinations – Qtern and Glyxambi – have now been approved for the treatment of type 2 diabetes. This article discusses their clinical trial efficacy, adverse effects and place in therapy

More details...

Communication in the age of digital healthcare

The surge of technology across healthcare is washing away labour-intensive practices and promises a cleaner, smarter future for GPs and prescribers. However, concern is growing that traditional lines of clinical communication could be drowned out by the race for progress across a troubled

More details...

Sarilumab: a new IL-6 receptor blocker for rheumatoid arthritis

Sarilumab (Kevzara) is the second monoclonal antibody against the IL-6 receptor to be licensed for the treatment of rheumatoid arthritis. This article examines its indications, efficacy and adverse effects

More details...

Straining to communicate

David Delvin recounts the benefits and pitfalls of resorting to mime when trying to communicate your embarrassing medical needs in a foreign country

More details...

Web design and marketing agency Leamington Spa